Bandwidth Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bandwidth Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $204.11M | Feb 15, 2019 |
| FY2018 | Dec 31, 2017 | $162.96M | Feb 15, 2019 |
| FY2018 | Dec 31, 2016 | $152.14M | Feb 15, 2019 |
| FY2017 | Dec 31, 2015 | $137.80M | Feb 26, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $753.82M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $748.49M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $601.12M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $573.15M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $490.91M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $343.11M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $232.59M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $204.11M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $162.96M | Feb 21, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $279.96M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $236.16M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $238.35M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $213.81M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $153.91M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $107.64M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $95.97M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $73.69M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $66.92M | Feb 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.91M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($6.52M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($16.34M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $19.57M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($27.36M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($43.98M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.49M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $17.92M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $5.97M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $22.36M | Feb 15, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.37M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($20.06M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($35.46M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($24.32M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($2.24M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($13.51M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($17.69M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $6.75M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $14.62M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $15.24M | Feb 15, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $132.52M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $118.63M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $104.19M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $97.99M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $69.51M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $54.56M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $31.46M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $20.90M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $10.79M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $8.52M | Feb 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.49M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $83.88M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $39.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $34.91M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $40.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $4.52M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($1.25M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $24.63M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $14.62M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $5.15M | Feb 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $12.27M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $22.22M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $12.42M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $5.02M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $3.83M | Feb 15, 2019 |
| FY2017 | Dec 31, 2015 | $2.09M | Feb 26, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $989.17M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.10B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $929.32M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $890.61M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $341.42M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $150.42M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $104.49M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $69.97M | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $652.65M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $676.63M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $803.66M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $657.14M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $652.94M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $460.69M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $71.33M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $41.65M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $27.78M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $70.53M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $399.97M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $312.53M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $297.39M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $272.18M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $412.60M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $429.92M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $270.09M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $108.77M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $76.71M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | ($22.37M) | Feb 21, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $356.77M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $317.24M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $335.87M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $326.41M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $344.42M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $372.24M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $6.87M | Feb 25, 2022 |
| FY2019 | Dec 31, 2018 | $6.87M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $6.87M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.87M | Feb 26, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($84.33M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($71.41M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($64.89M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | ($48.55M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($76.87M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($49.51M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($5.53M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($7.85M) | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | ($25.77M) | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | ($31.74M) | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.79M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $81.81M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $131.99M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $113.64M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $331.45M | Feb 28, 2024 |
| FY2021 | Dec 31, 2020 | $72.16M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $184.41M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $41.26M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $37.63M | Feb 15, 2019 |
| FY2018 | Dec 31, 2016 | $6.79M | Feb 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $282.20M | Mar 1, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 15, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 15, 2019 |